Bijoy Hans Limited has announced that its equity shares have been delisted from the Calcutta Stock Exchange Limited with effect from March 18, 2026. The company received an official delisting order dated March 17, 2026, from the Calcutta Stock Exchange Limited regarding this development.

Delisting Details

The delisting has been implemented under the SEBI (De-listing of Equity Shares) Regulations, 2021, following approval for voluntary delisting by the exchange. The company made this disclosure pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Continued BSE Listing

Bijoy Hans Limited has emphasized that the delisting from Calcutta Stock Exchange Limited does not impact its listing status on other exchanges. The company's equity shares continue to remain listed on BSE Limited, where they trade under scrip code 524723. Trading activities on BSE Limited remain completely unaffected by the Calcutta Stock Exchange delisting.

Official Communication

The announcement was signed by Kaushal Uttam Shah, Managing Director of Bijoy Hans Limited (DIN: 02175130), and communicated to both BSE Limited and Calcutta Stock Exchange Limited. The Calcutta Stock Exchange issued its official notice through Chandran Datta, OSD & Company Secretary, confirming the voluntary delisting approval.

This development represents a strategic move by the company to streamline its exchange listings while maintaining its presence on BSE Limited for continued trading operations.

Bijoy Hans Limited has received official approval from the Registrar of Companies (ROC), Central Registration Centre (CRC), and Ministry of Corporate Affairs (MCA) for its proposed name change to 'Arvaya Healthcare Limited.' This development follows the company's recent board decisions regarding corporate rebranding strategy.

ROC Approval Details

The Ministry of Corporate Affairs issued the name availability approval on March 12, 2026, through the Central Registration Centre in Manesar. The approval was processed under Section 4(5) of the Companies Act, 2013, following the company's application dated March 11, 2026.

Board Meeting and Strategic Decisions

The company's Board of Directors had convened on March 11, 2026, where they approved the name change proposal subject to regulatory approvals. This decision came after the board had previously withdrawn an earlier approved name change to 'Arvaya Healthtech Limited' due to revised strategic business decisions.

Regulatory Compliance and Next Steps

The ROC approval comes with specific conditions and time constraints. The name availability is valid for 60 days from the approval date and does not grant any inherent rights or privileges. The approval is subject to compliance with Sections 4(2), 4(3), and other applicable provisions of the Companies Act, 2013.

Bijoy Hans Limited will now proceed to obtain shareholder approval for the name change, with a separate intimation to be filed with stock exchanges upon completion. The company has communicated this development to BSE Limited and The Calcutta Stock Exchange Limited in compliance with Regulation 30 of SEBI Listing Regulations.

Corporate Information

Bijoy Hans Limited, incorporated with CIN L86100AS1985PLC002323, trades on BSE with scrip code 524723 and on The Calcutta Stock Exchange with scrip code 012097. The regulatory communication was signed by Company Secretary and Compliance Officer Guinea Agrawal (Membership No: A60654), ensuring proper disclosure to all stakeholders and regulatory authorities.